Nuts the Nomura research report that everyone loved with the 31 cents price target,have us down for $1m revenue full year 2014 ?????
And this is what they had to say about the the next cap raise.........
""Further capital raising may be required: We believe it is likely that PRR will have to come back to the market to continue its Phase III clinical trials. After a successful
capital raising, PRR had AUD56mn in cash as at 30 June 2011. It plans an 800-patient clinical trial. We believe the cost of performing a Phase III clinical trial can be up to USD60K per patient or more. If this is the case, then it would cost USD48mn for the clinical trial. This does not include other costs including infrastructure;""
announcement, page-82
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $2.355M | 7.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 128197 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |